3-(4-Methyl-1H-pyrazol-1-yl)benzoic acid, 98%, 250mg

N-(4-methylphenyl)methanesulfonamide, 95.0%, 250mg

5,7-dimethyl-1,4-dihydroquinolin-4-one, 96%, 10g

2,5-DIBROMO-4-HYDROXYBENZONITRILE, 95.0%, 1g

2-Undecyl-1H-imidazole, 95.0%, 100g

1-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 97.0%, 250mg

Capilar de punto de fusión, 100 mm, 1,55 mm, 1,15 mm, 1000 Unidad(es)

4-Methylumbelliferyl 2-Acetamido-2-deoxy-beta-D-galactopyranoside>98.0%(HPLC)250mg

2-(4-(TRIFLUOROMETHYL)PHENYL)MORPHOLINE, 95.0%, 250mg

Methyl 4-formylthiophene-3-carboxylate, 98%, 1g

2-Iodo-5-methylaniline, 98.0%, 100g

2-[2-(4-acetamidobenzenesulfonamido)-1,3-thiazol-4-yl]acetic acid, 95.0%, 2.5g

Cis,cis-cyclohexane-1,3,5-tricarboxylic acid, 97.0%, 100g